| 17/05/21 | 07:00:12 | 17 May 2021 | | Bexmarilimab shows promising anti-tumour activity | RNS |
| 14/05/21 | 07:00:03 | 14 May 2021 | | US rights to patent related to Traumakine | RNS |
| 10/05/21 | 14:30:02 | 10 May 2021 | | Holding(s) in Company | RNS |
| 29/04/21 | 12:45:03 | 29 Apr 2021 | | Grant of options | RNS |
| 23/04/21 | 13:45:02 | 23 Apr 2021 | | Board Change | RNS |
| 23/04/21 | 13:45:02 | 23 Apr 2021 | | Result of AGM | RNS |
| 29/03/21 | 07:00:10 | 29 Mar 2021 | | Appointment of a Broker | RNS |
| 25/03/21 | 07:45:06 | 25 Mar 2021 | | Exercise of Options | RNS |
| 25/03/21 | 07:30:05 | 25 Mar 2021 | | Notice of Faron Pharmaceuticals Ltd’s AGM | RNS |
| 25/03/21 | 07:15:06 | 25 Mar 2021 | | Faron´s Annual Report 2020 published | RNS |
| 25/03/21 | 07:00:08 | 25 Mar 2021 | | Financial statement January 1 to December 31 2020 | RNS |
| 22/03/21 | 07:00:07 | 22 Mar 2021 | | Bexmarilimab (Clevegen) development update | RNS |
| 11/03/21 | 07:00:12 | 11 Mar 2021 | | Faron to Present at Oppenheimer Conference | RNS |
| 02/03/21 | 07:00:05 | 2 Mar 2021 | | Faron to Present at H.C. Wainwright Conference | RNS |
| 25/02/21 | 07:00:08 | 25 Feb 2021 | | Notice of Full-Year Results and Annual Report | RNS |
| 17/02/21 | 16:30:01 | 17 Feb 2021 | | Holding(s) in Company | RNS |
| 12/02/21 | 15:00:00 | 12 Feb 2021 | | Registration of Placing Shares | RNS |
| 12/02/21 | 07:00:04 | 12 Feb 2021 | | Results of Placing and Issue Price | RNS |
| 11/02/21 | 16:30:06 | 11 Feb 2021 | | Proposed Issue and Placing of Shares | RNS |
| 26/01/21 | 07:00:02 | 26 Jan 2021 | | Update on TRAUMAKINE development | RNS |
| 20/01/21 | 14:06:29 | 20 Jan 2021 | | Second Price Monitoring Extn | RNS |
| 20/01/21 | 14:01:07 | 20 Jan 2021 | | Price Monitoring Extension | RNS |
| 20/01/21 | 07:00:03 | 20 Jan 2021 | | Bexmarilimab (Clevegen) development update | RNS |
| 18/01/21 | 14:05:44 | 18 Jan 2021 | | Second Price Monitoring Extn | RNS |
| 18/01/21 | 14:00:39 | 18 Jan 2021 | | Price Monitoring Extension | RNS |
| 18/01/21 | 11:06:16 | 18 Jan 2021 | | Second Price Monitoring Extn | RNS |
| 18/01/21 | 11:01:11 | 18 Jan 2021 | | Price Monitoring Extension | RNS |
| 18/01/21 | 07:00:06 | 18 Jan 2021 | | US Department of Defense to support TRAUMAKINE | RNS |
| 04/01/21 | 07:00:11 | 4 Jan 2021 | | Faron to Present at H.C. Wainwright | RNS |
| 21/12/20 | 07:00:07 | 21 Dec 2020 | | Faron’s financial calendar for 2021 | RNS |
| 10/12/20 | 07:00:06 | 10 Dec 2020 | | Presents at ESMO Immuno-Oncology Virtual Congress | RNS |
| 23/11/20 | 07:30:06 | 23 Nov 2020 | | To Participate in Upcoming Investor Conferences | RNS |
| 23/11/20 | 07:00:07 | 23 Nov 2020 | | Bexmarilimab (Clevegen) development update | RNS |
| 20/11/20 | 07:00:03 | 20 Nov 2020 | | Issue of Equity | RNS |
| 16/10/20 | 11:35:06 | 16 Oct 2020 | | First Results from WHO Solidarity Trial | RNS |
| 14/10/20 | 14:15:01 | 14 Oct 2020 | | Grant of options | RNS |
| 24/09/20 | 07:15:01 | 24 Sept 2020 | | Exercise of options | RNS |
| 24/09/20 | 07:00:04 | 24 Sept 2020 | | Half-year Report | RNS |
| 18/09/20 | 07:00:02 | 18 Sept 2020 | | MATINS trial data presented at ESMO | RNS |
| 09/09/20 | 12:00:01 | 9 Sept 2020 | | Faron to Present at H.C. Wainwright Conference | RNS |
| 27/08/20 | 07:00:07 | 27 Aug 2020 | | Notice of Half-Year Report | RNS |
| 18/08/20 | 07:00:04 | 18 Aug 2020 | | Traumakine Update | RNS |
| 17/08/20 | 16:41:38 | 17 Aug 2020 | | Second Price Monitoring Extn | RNS |
| 17/08/20 | 16:36:00 | 17 Aug 2020 | | Price Monitoring Extension | RNS |
| 27/07/20 | 07:00:10 | 27 Jul 2020 | | Change of Adviser | RNS |
| 20/07/20 | 16:41:40 | 20 Jul 2020 | | Second Price Monitoring Extn | RNS |
| 20/07/20 | 16:35:39 | 20 Jul 2020 | | Price Monitoring Extension | RNS |
| 08/07/20 | 15:00:05 | 8 Jul 2020 | | Managers’ transactions | RNS |
| 16/06/20 | 07:01:00 | 16 Jun 2020 | | Faron hosts virtual R&D Day today | RNS |
| 16/06/20 | 07:00:04 | 16 Jun 2020 | | Faron update on pipeline progress ahead of R&D Day | RNS |
